These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 28433512)
1. Effect of 1,2,3-triazole salts, non-classical bioisosteres of miltefosine, on Leishmania amazonensis. Stroppa PHF; Antinarelli LMR; Carmo AML; Gameiro J; Coimbra ES; da Silva AD Bioorg Med Chem; 2017 Jun; 25(12):3034-3045. PubMed ID: 28433512 [TBL] [Abstract][Full Text] [Related]
2. Novel functionalized 1,2,3-triazole derivatives exhibit antileishmanial activity, increase in total and mitochondrial-ROS and depolarization of mitochondrial membrane potential of Leishmania amazonensis. Meinel RS; Almeida ADC; Stroppa PHF; Glanzmann N; Coimbra ES; da Silva AD Chem Biol Interact; 2020 Jan; 315():108850. PubMed ID: 31634447 [TBL] [Abstract][Full Text] [Related]
3. Novel organic salts based on quinoline derivatives: The in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp. Calixto SL; Glanzmann N; Xavier Silveira MM; da Trindade Granato J; Gorza Scopel KK; Torres de Aguiar T; DaMatta RA; Macedo GC; da Silva AD; Coimbra ES Chem Biol Interact; 2018 Sep; 293():141-151. PubMed ID: 30098941 [TBL] [Abstract][Full Text] [Related]
4. Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis. Cavalcanti de Queiroz A; Alves MA; Barreiro EJ; Lima LM; Alexandre-Moreira MS Exp Parasitol; 2019 Jun; 201():57-66. PubMed ID: 31004571 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of novel 4-aminoquinoline/1,2,3-triazole hybrids against Leishmania amazonensis. Glanzmann N; Antinarelli LMR; da Costa Nunes IK; Pereira HMG; Coelho EAF; Coimbra ES; da Silva AD Biomed Pharmacother; 2021 Sep; 141():111857. PubMed ID: 34323702 [TBL] [Abstract][Full Text] [Related]
6. 4-Aminoquinoline Derivatives as Potential Antileishmanial Agents. Antinarelli LM; Dias RM; Souza IO; Lima WP; Gameiro J; da Silva AD; Coimbra ES Chem Biol Drug Des; 2015 Oct; 86(4):704-14. PubMed ID: 25682728 [TBL] [Abstract][Full Text] [Related]
7. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species. Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714 [TBL] [Abstract][Full Text] [Related]
8. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species. Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis. Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917 [TBL] [Abstract][Full Text] [Related]
10. A novel alkyl phosphocholine-dinitroaniline hybrid molecule exhibits biological activity in vitro against Leishmania amazonensis. Godinho JL; Georgikopoulou K; Calogeropoulou T; de Souza W; Rodrigues JC Exp Parasitol; 2013 Sep; 135(1):153-65. PubMed ID: 23845259 [TBL] [Abstract][Full Text] [Related]